This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Simon R . Importance of prognostic factors in cancer clinical trials Cancer Treat Rep 1984 68: 185–192
Aguayo A, Estey E, Kantarjian H et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia Blood 1999 94: 3717–3721
Estey EH, Shen Y, Thall PF . Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB Blood 2000 95: 72–77
Altman DG, Lausen B, Sauerbrei W, Schumaker M . The dangers of using ‘optimal cutpoints’ in the evaluation of prognostic factors J Natl Cancer Inst 1994 86: 829–835
Thall P, Estey E . Graphical methods for evaluating covariate effects in the Cox model In: Crowley J (ed). Handbook of Statistics in Clinical Oncology Marcel-Dekker: New York (in press)
Estey EH, Thall PF, Pierce S et al. Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/− all-trans retinoic acid +/− granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome Blood 1999 93: 2478–2484
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Estey, E. Prognostic factors in acute myelogenous leukemia. Leukemia 15, 670–672 (2001). https://doi.org/10.1038/sj.leu.2402057
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402057
This article is cited by
-
Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia
Journal of Hematology & Oncology (2016)
-
Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies
Scientific Reports (2016)
-
Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: evidence based on a meta-analysis
Tumor Biology (2014)
-
High expression of FCHSD2 is associated with chemoresistance in adult acute myeloid leukemia
Comparative Clinical Pathology (2014)
-
Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis
Tumor Biology (2014)